KF
ALDX icon

Krilogy Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Krilogy Financial’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26K Buy
+14,459
New +$63.3K ﹤0.01% 963
2025
Q4 		– Sell
-10,407
Closed -$51.3K – 924
2025
Q3 		$51.3K Buy
+10,407
New +$54.3K ﹤0.01% 852

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Krilogy Financial's ALDX Position: Q1 2026 in Review

Krilogy Financial opened a new position in Aldeyra Therapeutics (ALDX) in Q1 2026: 14,459 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #963 among its holdings. This is a return to the name: Krilogy Financial previously reported a position in ALDX as recently as Q3 2025.

Krilogy Financial first reported a position in ALDX in Q3 2025 and has held it in 2 quarters since. The position peaked at $51.3K in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Krilogy Financial held 14,459 shares of Aldeyra Therapeutics worth $26K as of Q1 2026.
  • Aldeyra Therapeutics was a new Krilogy Financial position in Q1 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Krilogy Financial's portfolio in Q1 2026, its #963 holding.
  • Krilogy Financial first reported a position in Aldeyra Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Krilogy Financial's Aldeyra Therapeutics position peaked at $51.3K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.